WA
MD icon

Winfield Associates’s Pediatrix Medical MD Stock Holding History

Winfield Associates’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-90
Closed -$5K – 421
2017
Q4 		$5K Buy
+90
New +$4.25K ﹤0.01% 521
2017
Q2 		– Sell
-50
Closed -$3K – 893
2017
Q1 		$3K Hold
50
– – ﹤0.01% 539
2016
Q4 		$3K Buy
+50
New +$3.25K ﹤0.01% 510

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Winfield Associates's MD Position: Q1 2018 in Review

Winfield Associates sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 90 shares — an estimated $5K sold.

Winfield Associates first reported a position in MD in Q4 2016 and held it in 3 quarters. The position peaked at $5K in Q4 2017. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Winfield Associates reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 90 Pediatrix Medical shares in Q1 2018, an estimated $5K.
  • Winfield Associates first reported a position in Pediatrix Medical in Q4 2016 and held it in 3 quarters.
  • Winfield Associates's Pediatrix Medical position peaked at $5K in Q4 2017.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.